Thermodynamic and kinetic limitations can restrict the feasibility and scalability of conventional catalytic processes for CO 2 methanation at the industrial level. Due to its nonequilibrium nature, nonthermal plasma (NTP) promises to reduce reaction barriers and make this gas conversion approach viable even at low temperatures. However, the current understanding of the fundamental chemical and physical behaviors in the hybrid plasma catalytic interactions is insufficient. This study demonstrates plasma-driven CO 2 conversions approaching the reaction equilibrium with high methane yields even at low temperature (150 °C). It was observed that the addition of plasma to the catalytic bed enhanced the CO 2 conversion around 20 times relative to thermal activity, whereas the CH 4 selectivity increased around 5 times by introducing the nickel catalyst into plasma discharge compared to plasma only (at 150 °C). Moreover, the findings provide new insights into the gas phase activation of reactants (CO 2 and H 2 ) and the reaction over Ni 0 to decouple the plasma and catalyst synergy. The catalyst did not undergo significant structural changes under plasma discharge, apart from a slight decrease in Ni crystallite size, while an enhanced metal dispersion was evident (24% to 42%, from CO pulse chemisorption). The optimized system achieved a CO 2 conversion of 60% with a CH 4 selectivity of over 97% at 150 °C, which required much higher temperatures (320–330 °C) to achieve equivalent conversion in thermal catalysis. This study is a step toward an understanding and effective control of the plasma enhanced catalytic CO 2 transformation via low energy reaction pathways that utilize the NTP for low-temperature CO 2 methanation with high conversion, selectivity, stability, and controllability.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: